Acute Myeloid Leukemia Panel

Available viaHome Collection
GenderMale & Female
Contains23 parameters
Earliest reports inNext Day
PreparationNo preparation needed

Overview of Acute Myeloid Leukemia Panel in Pathanamthitta

The Acute Myeloid Leukemia (AML) Panel is a specialised flow cytometry (FCM) test used to identify and classify abnormal myeloid blast cells in blood or bone marrow samples. It evaluates a panel of immunophenotypic markers to determine the lineage and characteristics of leukemia cells, helping distinguish AML from other types of acute leukemia. The information obtained from this test supports accurate diagnosis, disease classification, and treatment planning, making it an important part of the initial evaluation of suspected AML.

 Who Should Get This Test Done?

  This test may be recommended for:

●     Individuals with suspected acute myeloid leukemia based on blood counts or bone marrow findings.

●     Individuals with unexplained fatigue, persistent fever, recurrent infections, easy bruising, or abnormal bleeding.

●     Individuals with blast cells detected on a peripheral blood smear or bone marrow examination.

●     Individuals requiring immunophenotyping to confirm and classify acute leukemia.

●     Individuals undergoing evaluation or follow-up for acute myeloid leukemia as advised by their hematologist or oncologist.

Why Consider This Test?

●     Helps confirm the diagnosis of acute myeloid leukemia.

●     Differentiates AML from acute lymphoblastic leukemia and other hematological malignancies.

●     Identifies the immunophenotypic profile of abnormal blast cells using flow cytometry.

●     Supports disease classification, which is important for treatment planning.

●     Provides detailed information that complements bone marrow examination, cytogenetic, and molecular studies.

 More Information

The Acute Myeloid Leukemia Panel analyses the expression of multiple myelomonocytic, erythroid, megakaryocytic, lymphoid, and non-lineage-specific markers using flow cytometry. Markers such as CD13, CD33, CD117, CD34, HLA-DR, CD45, CD41, CD61, Glycophorin A, CD7, CD56, and CD19 help determine the origin and characteristics of abnormal blast cells. The results are interpreted together with clinical findings, blood counts, bone marrow morphology, cytogenetic analysis, and molecular testing to provide a comprehensive evaluation of AML.

 Other Names

●     Acute Myeloid Leukemia Immunophenotyping Panel

●     AML Panel by Flow Cytometry

●     Acute Myeloid Leukemia FCM Panel

●     Flow Cytometry for Acute Myeloid Leukemia

●     AML Immunophenotyping Test

Test included

Acute Myeloid Leukemia Panel includes 23 parameters

  • Cd45

  • Cd11b
  • Cd13
  • Cd14
  • Cd15
  • Cd16
  • Cd33
  • Cd64
  • Cd117

  • Glycophorin A

  • Cd41
  • Cd61

  • Cd7
  • Cd56

  • Cd19

  • Cd34
  • Hla Dr

  • Instrument/software Used
  • Cell Preparation Method
  • Gating Strategy
  • Specimen Type
  • Wbc Count
  • Blast

Test code

1047

CPT and Loinc codes

Department

  • Flow Cytometry

Turn around time

Next Day

Performing locations

3 labs across India

Specimen vol. and vacutainer information

SpecimenVacutainerVolume
Bone MarrowOthers10
Edta Whole BloodLavender Vacutainer11 ML
Heparin Whole BloodGreen Vacutainer11 ML
SmearOthers10

Specimen stability information

Edta Whole Blood, Heparin Whole Blood, Smear

Collection instructions

2-3 unfixed, unstained direct smears + Detailed Clinical history medatory, Fluid send in RPMI 1:1 in plain container

Acute Myeloid Leukemia Panel

₹11550

Health Checkup Category

Complete Care Packages

ACUTE MYELOID LEUKEMIA PANEL Package in Other Cities

Need Assistance? Call 93334-93334 or Request a Callback from our health advisor!